SEC Company Response from Inari Medical, Inc. (NARI) (CIK 0001531048) — May 19, 2020
Inari Medical, Inc. (NARI) (CIK 0001531048)
Date: May 19, 2020 · CIK: 0001531048 · Accession: 0001193125-20-146173
AI Filing Summary & Sentiment
File numbers found in text: 333-236568
Letter
Inari Medical, Inc.
9 Parker, Suite 100
Irvine, California 92618
May 19, 2020
VIA EDGAR TRANSMISSION
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Chris Edwards; Irene Paik; Jeanne Bennett; Kevin Kuhar
Re: Inari Medical, Inc.
Registration Statement on Form S-1 (File No. 333-236568)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1, as amended (File No. 333-236568) (the “Registration Statement”) of Inari Medical, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern Time, on May 21, 2020, or as soon as practicable thereafter, or at such later time as the Company may orally request via telephone call to the staff of the U.S. Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Shayne Kennedy at (714) 755-8181 or, in his absence, Ross McAloon at (714) 755-8051.
Thank you for your assistance in this matter.
Very truly yours,
Inari Medical, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Inari Medical, Inc. 9 Parker, Suite 100 Irvine, California 92618 May 19, 2020 VIA EDGAR TRANSMISSION United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Chris Edwards; Irene Paik; Jeanne Bennett; Kevin Kuhar Re: Inari Medical, Inc. Registration Statement on Form S-1 (File No. 333-236568) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1, as amended (File No. 333-236568) (the “Registration Statement”) of Inari Medical, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern Time, on May 21, 2020, or as soon as practicable thereafter, or at such later time as the Company may orally request via telephone call to the staff of the U.S. Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Shayne Kennedy at (714) 755-8181 or, in his absence, Ross McAloon at (714) 755-8051. Thank you for your assistance in this matter. Very truly yours, Inari Medical, Inc. By: /s/ William Hoffman William Hoffman Chief Executive Officer cc: B. Shayne Kennedy, Latham & Watkins LLP J. Ross McAloon, Latham & Watkins LLP